Why is Soni Medicare falling/rising?

As of 01-Aug, Soni Medicare Ltd is currently priced at 58.20, reflecting a slight increase of 0.2, or 0.34%. The stock has outperformed its sector today by 0.89% and is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past month, Soni Medicare has shown a significant return of 15.25%, while its performance over the past year has been remarkable at 114.44%. However, it is important to note that the stock has experienced a decline in investor participation, with delivery volume falling by 98.82% compared to the 5-day average. The company has an attractive valuation with a return on capital employed (ROCE) of 7.7 and is trading at a discount relative to its peers, despite facing challenges such as a high debt-equity ratio of 6.6 and reported losses.
In the broader market context, while the BSE500 index has generated negative returns of -4.13% over the last year, Soni Medicare has managed to outperform significantly, indicating strong market-beating performance. However, the stock's recent upward movement may be tempered by its high debt levels and weak long-term fundamental strength, which could raise concerns among investors. The stock's ability to maintain its upward trajectory will depend on addressing these financial challenges while continuing to leverage its attractive valuation and strong returns relative to the broader market.